Tissue Banking Market Trends Report, 2020-2025 - Global Burden of Chronic Diseases Expected to Reach 57% in 2020

News provided by

Mar 11, 2020, 09:45 ET

DUBLIN, March 11, 2020 /PRNewswire/ -- The "Tissue Banking Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The global tissue banking market is expected to witness a CAGR of 8.5% during the forecast period.

Certain factors that are driving the market growth include rising healthcare expenditure, the growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately 60% of all deaths worldwide.

The global burden of chronic diseases is expected to reach 57%, by 2020. This trend is expected to affect the emerging countries the most, as population growth is anticipated to be most significant in developing areas. Consequently, the rising burden of chronic diseases is expected to drive the overall growth of the tissue banking market. However, the stringent regulatory scenario is expected to restrain the growth of the global market in the forecast period.

Key Market Trends

Equipment Segment is Expected to Show Better Growth in the Forecast Period

Based on the product, it is segmented into equipment and media and consumables. The equipment segment is expected to grow at a faster pace during the forecast period. The key factor contributing to the growth of the segment is mainly driven by growing research activities and increasing the focus of market players on product development, along with the rising burden of chronic diseases.

According to the World Health Organization (WHO), the four major chronic diseases which include cardiovascular diseases followed by cancer, respiratory diseases, and diabetes account for most deaths. Factors, such as the aging population, lifestyle changes, lead to long-term health problems, and their treatment can be expensive. Additionally, Increasing government initiatives and rising demand for transplantation is expected to boost the studied market.

North America is Estimated to Account for the Largest Share in the Tissue Banking Market

North America holds a major share in the global tissue banking market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The United States market is driven by increasing R&D activities, along with the rising burden of chronic diseases.

According to the Center for Disease Control and Prevention (CDC), 6 in 10 adults in the United States have a chronic disease. Different pharmaceutical/ biotech companies, academia, and research institutes are utilizing tissue banks for the storage of the various samples. Hence, the North America region is expected to grow at a faster rate due to rising preclinical activities by pharmaceutical companies, and growing research in this region.

Competitive Landscape

The leading players in the tissue banking market are AMS Biotechnology (Europe) Limited, Avantor, Inc (VWR International), BioCision LLC, Brooks Automation, Custom Biogenic Systems, Eppendorf AG, Hamilton Company, Merck KGaA and Thermo Fisher Scientific, Inc.

Key Topics Covered

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Healthcare Expenditure
4.2.2 Growing Burden of Chronic Diseases
4.2.3 Technological Advances in Drug Discovery and Development
4.3 Market Restraints
4.3.1 Stringent Regulatory Scenario
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Equipment
5.1.1.1 Cryopreservation Equipment
5.1.1.2 Thawing Equipment
5.1.1.3 Quality Control Equipment
5.1.1.4 Others
5.1.2 Media and Consumables
5.2 By Application
5.2.1 Therapeutics
5.2.2 Medical Research
5.2.3 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AMS Biotechnology (Europe) Limited
6.1.2 Avantor, Inc (VWR International)
6.1.3 BioCision LLC
6.1.4 Brooks Automation, Inc.
6.1.5 Custom Biogenic Systems
6.1.6 Eppendorf AG
6.1.7 Hamilton Company
6.1.8 Merck KGaA
6.1.9 Thermo Fisher Scientific, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/5zxqen

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets